2030 年 DNA 定序市场预测：按产品、技术、用途、最终用户和地区进行的全球分析

根据 Stratistics MRC 的数据，2023 年全球 DNA 定序市场规模将达到 125 亿美元，预计在预测期内将以 19.1% 的年复合成长率成长，到 2030 年将达到 425 亿美元。

DNA 定序是一种使用广泛的平行性来确定不同 DNA 链序列的过程。与微阵列和其他遗传分析技术相比，DNA 定序的优点包括成本低、准确度高、速度快，即使输入样本量少也能得到可靠的结果。 DNA 定序的用途包括生物标记鉴定、肿瘤学研究、个体化医疗保健和法医学。

据国家人类基因组研究所称，持续的技术创新将导致 2021 年 8 月每个基因组的 NGS 成本为 562 美元，每兆碱基为 0.006 美元。

基因组定序需求不断成长

DNA 定序产业对基因组定序的需求量很大，因为它彻底改变了各个领域。此外，由于基因诊断、个人化医疗和癌症研究中对基因组定序的需求，临床应用也不断增加。此外，随着基因组学不断揭示潜在的疾病机制和潜在的治疗方法，对基因组定序的需求预计会增加。这将加速 DNA 定序仪的新产品开发和市场开拓。

高成本

DNA 定序技术的高成本是市场的主要障碍。这些成本包括设备、消耗品和资料处理，使得定序配合措施通常在经济上造成负担。此外，定序计画需要研究机构、临床实验室和医疗机构提供大量资金，而高昂的成本限制了尖端定序技术的取得，特别是在资源有限的环境中，并可能阻碍普及。这阻碍了市场的扩张。

DNA定序技术的进步

DNA 定序技术的发展彻底改变了基因组研究和临床应用。此外，Illumina和Oxford Nanopore等公司的次世代定序（NGS）技术使高通量定序成为可能。此外，这些发展使得大规模基因组研究变得更加经济实惠，并加快了资料收集速度。单分子定序和长读长技术提高了 DNA 序列的准确性，使得分析复杂的基因组区域变得更容易。此外，它允许研究人员和临床医生在从农村地区到临床设施的各种环境中进行定序活动，从而提高了基因组学的可及性和有效性。因此，这些要素是市场扩张的主要驱动力。

与隐私和资料分析相关的风险

DNA 定序市场一直受到隐私问题的阻碍。随着基因检测的使用增加，人们和组织对敏感基因资料的安全性和潜在滥用提出了担忧。此外，这阻碍了人们参与基因研究和与医疗保健专业人员共用资讯，从而减缓了基因组学研究和治疗应用的发展。此外，现代定序技术会产生大量资料，造成巨大的计算和资料分析障碍，阻碍有效的解释和利用。

COVID-19 的影响

DNA 定序市场受到了 COVID-19 爆发的负面影响。疫情扰乱了供应链，限制了实验室的使用，并给医疗机构造成了财务限制，从而影响了测序计划和非大流行项目的研究经费。儘管有这些挑战，大流行加速了定序在感染疾病研究中的引入，并逐渐限制了市场扩张。

预计消耗品领域在预测期内将是最大的

由于文库建构各个阶段（包括 DNA 片段化、富集、接头连接、扩增和品管）的试剂和试剂盒广泛可用，消耗品部分预计将占据最大份额。它还包括用于样品製备和分析的消耗品、流通池、引子、缓衝液和定序试剂。消耗品对于定序工作流程至关重要，因为它们可确保 DNA 序列的准确性和有效性。因此，消耗品产业为製造商提供了重要且稳定的收入来源，对于基因组学研究、临床诊断和个人化医疗的进步至关重要。

次世代定序领域预计在预测期内年复合成长率最高

预计次世代定序领域将在预测期内出现良好的成长。 NGS 因其能够以实惠的价格产生高品质的序列资料而成为主流定序方法。此外，NGS 已被证明比传统定序技术更准确，使其适合癌症检测和基因组研究等用途。此外，称为次世代定序仪定序仪（NGS）系统的大规模平行定序仪可以在短时间内产生大量资料。因此，次世代定序仪技术凭藉其优越的准确性和检测能力，有望获得更大的市场占有率。

比最大的地区

由于该地区经济体的积极参与，亚太地区在预测期内获得了最大的市场占有率。此外，该地区许多国家启动了大规模的基因组学计划和研究计划。鼓励基因组在医疗保健中应用的重要倡议的例子包括日本的日本基因组医学计划和中国的精准医学计划。此外，政府资助以及与大企业的合作也支持该领域的创新。亚太地区庞大的人口为基因检测和个人化医疗创造了庞大的市场。因此，该地区正在成为扩大基因组研究和 DNA 定序领域的焦点。

复合年复合成长率最高的地区：

预计欧洲在预测期内的年复合成长率最高。该地区受益于充满活力的科学界、受人尊敬的研究机构以及促进基因组学研究创造力和金融投资的友好法规环境。此外，欧洲国家对医疗保健的大量投资增加了对个人化医疗、遗传诊断和药物基因组学中基因组应用的需求。此外，国际合作鼓励大规模基因组学配合措施，加剧该地区的竞争。因此，欧洲的全民健保体係有利于将基因组资料纳入临床实践并刺激市场扩张。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

• 公司简介
  • 其他市场参与者的综合分析（最多 3 家公司）
  • 主要企业SWOT分析（最多3家企业）
• 区域分割
  • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
• 竞争基准化分析
  • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

• 概述
• 利害关係人
• 调查范围
• 调查方法
  • 资料探勘
  • 资料分析
  • 资料检验
  • 研究途径
• 调查来源
  • 主要调查来源
  • 二次调查来源
  • 先决条件

第3章市场趋势分析

• 促进因素
• 抑制因素
• 机会
• 威胁
• 产品分析
• 技术分析
• 应用分析
• 最终用户分析
• 新兴市场
• 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

• 供应商的议价能力
• 买方议价能力
• 替代的威胁
• 新进入者的威胁
• 竞争公司之间的敌对关係

第5章全球 DNA 定序市场：副产品

• 消耗品
• 乐器
• 服务

第6章全球 DNA 定序市场：依技术分类

• 下一代定序
• 第三代DNA定序
• 其他技术

第7章全球 DNA 定序市场：依应用分类

• 肿瘤学
• 临床调查
• 法医学和农业基因组学
• 人类白血球抗原 (HLA) 分型
• 生殖健康
• 其他用途

第8章全球 DNA 定序市场：依最终用途

• 学术研究
• 临床调查
• 生物技术和製药公司
• 医院和诊所
• 其他最终用户

第9章全球 DNA 定序市场：按地区

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙
  • 其他欧洲国家
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 纽西兰
  • 韩国
  • 其他亚太地区
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 卡达
  • 南非
  • 其他中东和非洲

第10章进展

• 合约、伙伴关係、协作和合资企业
• 收购和合併
• 新产品发布
• 业务扩展
• 其他关键策略

第11章公司简介

• Agilent Technologies Inc.
• Pacific Biosciences of California Inc.
• Hamilton Thorne Biosciences
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Hoffmann-La Roche Ltd
• Illumina Inc.
• Merck KGaA
• Qiagen
• PerkinElmer Inc.
• Macrogen Inc.
• Myriad Genetics Inc.
• Eurofins Scientific

According to Stratistics MRC, the Global DNA Sequencing Market is accounted for $12.5 billion in 2023 and is expected to reach $42.5 billion by 2030 growing at a CAGR of 19.1% during the forecast period. DNA sequencing is a procedure that uses extensive parallelization to sequence different DNA strands. The advantages of DNA sequencing over microarray and other genetic analysis techniques include cheaper cost, higher accuracy and speed, and reliable results even with small sample input, applications for DNA sequencing include the identification of biomarkers, oncology research, individualized healthcare, forensics, and others.

According to National Human Genome Research Institute, due to continuous innovations, the cost of NGS per genome is USD 562, and the cost of NGS per megabase is USD 0.006 in August 2021.

Market Dynamics:

Driver:

Rising demand in genome sequencing

Genome sequencing is in greater demand in the DNA sequencing industry due to its transformational effects across a number of fields. Additionally, a rise in clinical applications is being caused by the necessity of genome sequencing in genetic diagnostics, customized medicine, and cancer research. Furthermore, the need for genome sequencing is anticipated to increase as genomics continues to shed light on the mechanisms underlying disease and potential treatments. Thus, this will encourage new product development and market expansion for DNA sequencing.

Restraint:

High cost

The high cost of DNA sequencing technologies is a key market obstacle. Equipment, consumables, and data processing are included in these costs, which frequently make sequencing efforts financially burdensome. Additionally, sequencing programs require huge amounts of cash from research institutions, clinical laboratories, and healthcare facilities, particularly in environments with limited resources, high expenses can restrict access to cutting-edge sequencing techniques and deter widespread adoption. Therefore, hampers the market expansion.

Opportunity:

Technological Advancements in DNA Sequencing

Genomic research and clinical applications have undergone a revolution due to technological developments in DNA sequencing. Additionally, high-throughput sequencing is made possible by next-generation sequencing (NGS) technologies from companies like Illumina and Oxford Nanopore. Moreover, because of the developments, large-scale genomic studies it has become more affordable, and data gathering has been speed up. The accuracy of DNA sequencing has increased because of single-molecule sequencing and long-read technologies, which also make it easier to analyze complex genomic areas. Furthermore, this has increased the accessibility and effect of genomics by enabling researchers and clinicians to conduct sequencing activities in a variety of contexts, from rural locations to clinical facilities. Therefore, these factors significantly have driven the market expansion.

Threat:

Risks associated with privacy and data analysis

The market for DNA sequencing has been hampered by privacy issues, as the use of genetic testing increases, people and organizations express concern about the security and potential abuse of highly sensitive genetic data. Additionally, this has made people hesitant to take part in genetic research and share information with healthcare professionals, which has slowed the development of genomics research and therapeutic applications. Furthermore, modern sequencing technologies create enormous amounts of data, which poses substantial computing and data analytic obstacles and hampers effective interpretation and utilization.

COVID-19 Impact

The market for DNA sequencing was negatively impacted by the COVID-19 epidemic. The pandemic impacted sequencing initiatives and research funding for non-pandemic projects by disrupting the supply chain, limiting laboratory access, and creating financial restrictions in healthcare institutions. Despite these challenges, the pandemic accelerated the adoption of sequencing for the research of infectious diseases, which gradually restrained market expansion.

The consumables segment is expected to be the largest during the forecast period

The consumables segment is estimated to hold the largest share, due to the widespread availability of reagents and kits for all library construction phases, including DNA fragmentation, enrichment, adapter ligation, amplification, and quality control. Additionally, this includes consumables used for sample preparation and analysis, flow cells, primers, buffers, and sequencing reagents. Consumables are essential to the sequencing workflow because they guarantee the precision and effectiveness of DNA sequencing. Therefore, the consumables industry provides manufacturers with a crucial and consistent source of income and is essential to the advancement of genomics research, clinical diagnostics, and customized medicine.

The next-generation sequencing segment is expected to have the highest CAGR during the forecast period

The next-generation sequencing segment is anticipated to have lucrative growth during the forecast period, due to its capacity to produce high-quality sequence data at affordable prices, NGS has become the predominant sequencing methodology. Furthermore, NGS has been shown to be more accurate than conventional sequencing techniques, making it appropriate for uses like cancer detection and genomics research. Moreover, massively parallel sequencers called next-generation sequencing (NGS) systems can produce a lot of data in a short amount of time. Therefore, due to its excellent accuracy and detection capacities, next-generation sequencing technology is anticipated to gain a greater market share.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to the active participation of the region's economies. Additionally, many nations in the region have started large-scale genomics initiatives and research plans. Examples of significant initiatives encouraging genomics applications in healthcare include Japan's "Japanese Genomic Medicine Program" and China's "Precision Medicine Initiative". Furthermore, governmental funding and partnerships with business titans are also encouraging innovation in the sector. The enormous population of the Asia-Pacific area creates a sizable market for genetic testing and tailored medicine. Thus, as a result, the area is gradually becoming a focus for genomics research and the expansion of the DNA sequencing sector.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period. The area benefits from a vibrant scientific community, esteemed research institutions, and a friendly regulatory environment that promotes creativity and financial investment in genomics research. Additionally, the demand for genomic applications in personalized medicine, genetic diagnostics, and pharmacogenomics has increased as a result of significant investments made in healthcare in European nations. Furthermore, large-scale genomics initiatives are encouraged by international cooperation, which raises the region's competitiveness. Therefore, the universal healthcare systems in Europe make it easier to incorporate genomic data into clinical practice, which stimulates market expansion.

Key players in the market:

Some of the key players in the DNA Sequencing Market include: Agilent Technologies Inc., Pacific Biosciences of California Inc., Hamilton Thorne Biosciences, Bio-Rad Laboratories Inc., Danaher Corporation, Hoffmann-La Roche Ltd, Illumina Inc., Merck KGaA, Qiagen, PerkinElmer Inc., Macrogen Inc., Myriad Genetics Inc. and Eurofins Scientific.

Key Developments:

In March 2023, llumina Inc. a global leader in DNA sequencing and array-based technologies, announced that its first product based on its novel Illumina Complete Long Read technology is now available to order.

In September 2022, Illumina, Inc. announced the launch of the NovaSeq™ X Series (NovaSeq X and NovaSeq X Plus), new production-scale sequencers that will push the limits of what is possible with genomic medicine, enabling faster, more powerful, and more sustainable sequencing.

In January 2019, NRGene and Macrogen Corp announced the launch of a joint sequencing-based genotyping service, ArrayMAGIC, at the Plant and Animal Genome (PAG) conference in San Diego.

Products Covered:

• Consumables
• Instruments
• Services

Technologies Covered:

• Next-Generation Sequencing
• Third Generation DNA Sequencing
• Other Technologies

Applications Covered:

• Oncology
• Clinical Investigation
• Forensics & Agrigenomics
• Human Leukocyte Antigen (HLA) Typing
• Reproductive Health
• Other Applications

End Users Covered:

• Academic Research
• Clinical Research
• Biotechnology & Pharmaceutical Companies
• Hospitals & Clinics
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global DNA Sequencing Market, By Product

• 5.1 Introduction
• 5.2 Consumables
• 5.3 Instruments
• 5.4 Services

6 Global DNA Sequencing Market, By Technology

• 6.1 Introduction
• 6.2 Next-Generation Sequencing
• 6.3 Third Generation DNA Sequencing
• 6.4 Other Technologies

7 Global DNA Sequencing Market, By Application

• 7.1 Introduction
• 7.2 Oncology
• 7.3 Clinical Investigation
• 7.4 Forensics & Agrigenomics
• 7.5 Human Leukocyte Antigen (HLA) Typing
• 7.6 Reproductive Health
• 7.7 Other Applications

8 Global DNA Sequencing Market, By End Use

• 8.1 Introduction
• 8.2 Academic Research
• 8.3 Clinical Research
• 8.4 Biotechnology & Pharmaceutical Companies
• 8.5 Hospitals & Clinics
• 8.6 Other End Users

9 Global DNA Sequencing Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Agilent Technologies Inc.
• 11.2 Pacific Biosciences of California Inc.
• 11.3 Hamilton Thorne Biosciences
• 11.4 Bio-Rad Laboratories Inc.
• 11.5 Danaher Corporation
• 11.6 Hoffmann-La Roche Ltd
• 11.7 Illumina Inc.
• 11.8 Merck KGaA
• 11.9 Qiagen
• 11.10 PerkinElmer Inc.
• 11.11 Macrogen Inc.
• 11.12 Myriad Genetics Inc.
• 11.13 Eurofins Scientific

List of Tables

• Table 1 Global DNA Sequencing Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 4 Global DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 5 Global DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
• Table 6 Global DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
• Table 7 Global DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
• Table 8 Global DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
• Table 9 Global DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 10 Global DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
• Table 11 Global DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
• Table 12 Global DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
• Table 13 Global DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
• Table 14 Global DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
• Table 15 Global DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
• Table 16 Global DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 17 Global DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
• Table 18 Global DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
• Table 19 Global DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
• Table 20 Global DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
• Table 21 Global DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 22 Global DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 23 North America DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
• Table 24 North America DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
• Table 25 North America DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 26 North America DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 27 North America DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
• Table 28 North America DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
• Table 29 North America DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
• Table 30 North America DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
• Table 31 North America DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 32 North America DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
• Table 33 North America DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
• Table 34 North America DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
• Table 35 North America DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
• Table 36 North America DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
• Table 37 North America DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
• Table 38 North America DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 39 North America DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
• Table 40 North America DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
• Table 41 North America DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
• Table 42 North America DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
• Table 43 North America DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 44 North America DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 45 Europe DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
• Table 46 Europe DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
• Table 47 Europe DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 48 Europe DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 49 Europe DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
• Table 50 Europe DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
• Table 51 Europe DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
• Table 52 Europe DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
• Table 53 Europe DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 54 Europe DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
• Table 55 Europe DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
• Table 56 Europe DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
• Table 57 Europe DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
• Table 58 Europe DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
• Table 59 Europe DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
• Table 60 Europe DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 61 Europe DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
• Table 62 Europe DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
• Table 63 Europe DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
• Table 64 Europe DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
• Table 65 Europe DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 66 Europe DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 67 South America DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
• Table 68 South America DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
• Table 69 South America DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 70 South America DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 71 South America DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
• Table 72 South America DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
• Table 73 South America DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
• Table 74 South America DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
• Table 75 South America DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 76 South America DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
• Table 77 South America DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
• Table 78 South America DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
• Table 79 South America DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
• Table 80 South America DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
• Table 81 South America DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
• Table 82 South America DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 83 South America DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
• Table 84 South America DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
• Table 85 South America DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
• Table 86 South America DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
• Table 87 South America DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 88 South America DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 89 Middle East & Africa DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
• Table 90 Middle East & Africa DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
• Table 91 Middle East & Africa DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 92 Middle East & Africa DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 93 Middle East & Africa DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
• Table 94 Middle East & Africa DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
• Table 95 Middle East & Africa DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
• Table 96 Middle East & Africa DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
• Table 97 Middle East & Africa DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 98 Middle East & Africa DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
• Table 99 Middle East & Africa DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
• Table 100 Middle East & Africa DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
• Table 101 Middle East & Africa DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
• Table 102 Middle East & Africa DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
• Table 103 Middle East & Africa DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
• Table 104 Middle East & Africa DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 105 Middle East & Africa DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
• Table 106 Middle East & Africa DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
• Table 107 Middle East & Africa DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
• Table 108 Middle East & Africa DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
• Table 109 Middle East & Africa DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 110 Middle East & Africa DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)